주식/증권
➡️ 중립
CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing
요약
Compass has said a rolling FDA application is already underway for its COMP360, with the package due to be completed in the fourth quarter of 2026 and a possible U.S. launch in the first half of 2027.